id: 663, Created by Stan Vick, Scout
Bioverativ (BIVV) $84M Shareholder Settlement
How it works?
- Company agreed to settle with investors to avoid further litigation
- We prepare documents and claim payout for you
Delaware court of ChanceryCourt
24 May 2017Class period Start
08 Mar 2018Class period End
This settlement of $84 million resolves claims over the acquisition of Bioverativ by Sanofi, whereby $BIVV stockholders received $105 in cash for each.
Failure to Disclose,
Breach of Fiduciary duty,
07 March 2018
Stewart N. Goldstein, M.D.
Prickett, Jones & Elliott, P.A., Cooch & Taylor P.A., Robbins Geller Rudman & Dowd LLP, Johnson Fistel LLP
John G. Cox, Anna Protopapas, Brian S. Posner, Louis J. Paglia, Geno J. Germano, John T. Greene, Andrea DiFabio, Alexander J. Denner
Gilardi & Co LLC
Settlement agreement date
Trades matching type
+$84,000,000Total Settlement Amount